TSS
BMY icon

Two Sigma Securities’s Bristol-Myers Squibb BMY Stock Holding History

Two Sigma Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,500
Closed -$2.74M – 1502
2024
Q4 		$2.74M Sell
48,500
-165,600
-77% -$9.25M 0.36% 32
2024
Q3 		$11.1M Sell
214,100
-218,700
-51% -$10.3M 0.19% 138
2024
Q2 		$18M Buy
432,800
+155,400
+56% +$6.95M 0.22% 88
2024
Q1 		$15M Buy
277,400
+18,800
+7% +$958K 0.15% 164
2023
Q4 		$13.3M Sell
258,600
-180,400
-41% -$9.47M 0.13% 169
2023
Q3 		$25.5M Buy
439,000
+379,100
+633% +$23.2M 0.27% 65
2023
Q2 		$3.83M Sell
59,900
-11,500
-16% -$771K 0.06% 373
2023
Q1 		$4.95M Buy
71,400
+4,300
+6% +$303K 0.1% 240
2022
Q4 		$4.83M Buy
67,100
+41,900
+166% +$3.16M 0.14% 155
2022
Q3 		$1.79M Sell
25,200
-123,800
-83% -$8.98M 0.05% 398
2022
Q2 		$11.5M Buy
149,000
+89,700
+151% +$6.83M 0.41% 41
2022
Q1 		$4.33M Buy
59,300
+51,800
+691% +$3.48M 0.15% 151
2021
Q4 		$468K Buy
7,500
+3,600
+92% +$211K 0.02% 559
2021
Q3 		$231K Sell
3,900
-63,500
-94% -$4.18M 0.01% 1161
2021
Q2 		$4.5M Buy
+67,400
New +$4.39M 0.14% 96
2021
Q1 		– Sell
-27,900
Closed -$1.73M – 920
2020
Q4 		$1.73M Buy
27,900
+1,000
+4% +$61.5K 0.04% 266
2020
Q3 		$1.62M Buy
26,900
+1,000
+4% +$60.2K 0.03% 249
2020
Q2 		$1.52M Sell
25,900
-23,200
-47% -$1.39M 0.03% 290
2020
Q1 		$2.74M Sell
49,100
-169,200
-78% -$10.3M 0.06% 199
2019
Q4 		$14M Buy
218,300
+57,200
+36% +$3.28M 0.09% 150
2019
Q3 		$8.17M Sell
161,100
-51,200
-24% -$2.41M 0.07% 199
2019
Q2 		$9.63M Buy
+212,300
New +$9.89M 0.1% 116
2019
Q1 		– Sell
-24,100
Closed -$1.25M – 1847
2018
Q4 		$1.25M Sell
24,100
-93,500
-80% -$5.02M 0.02% 544
2018
Q3 		$7.3M Sell
117,600
-154,500
-57% -$9.17M 0.05% 282
2018
Q2 		$15.1M Buy
272,100
+88,200
+48% +$4.76M 0.08% 200
2018
Q1 		$11.6M Buy
183,900
+170,700
+1,293% +$11M 0.07% 253
2017
Q4 		$809K Buy
+13,200
New +$826K 0.02% 494

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Two Sigma Securities's BMY Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,550 shares worth $262K. The stake represents 0.02% of the portfolio and ranks #978 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BMY as recently as Q3 2025.

Two Sigma Securities first reported a position in BMY in Q4 2016 and has held it in 29 quarters since. The position peaked at $18.8M in Q3 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Two Sigma Securities held 4,550 shares of Bristol-Myers Squibb worth $262K as of Q2 2026.
  • Bristol-Myers Squibb was a new Two Sigma Securities position in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #978 holding.
  • Two Sigma Securities first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 29 quarters since.
  • Two Sigma Securities's Bristol-Myers Squibb position peaked at $18.8M in Q3 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.